VANLENT ANNE 4

4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 2, 2021

Insider Transaction Report

Form 4
Period: 2021-11-30
VANLENT ANNE
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-11-30+14,00014,000 total
    Exercise: $2.17Exp: 2031-11-30Common Stock (14,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in equal monthly installments over one year from the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES